M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...

NomoLine capnography and gas monitoring, and regional oximetry. Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and ...

Learn more about whether Masimo Corporation or STERIS plc is a better investment based on AAII's A+ Investor grades, which ...

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of $1.80 in the fourth quarter of 2024, up 44% year over year. The figure beat the Zacks Consensus Estimate by 20.8%. Find the ...

key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 earnings beat. The company is moving quickly with ...

Q4 2024 Earnings Call Transcript February 25, 2025 Masimo Corporation beats earnings expectations. Reported EPS is $1.67, expectations were $1.42. Operator: Good afternoon, ladies and gentlemen, and ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo Corporation MASI delivered adjusted ... CO-Oximetry and hemodynamics, capnography and gas and brain monitoring exceeding their respective growth targets. Non-healthcare revenues in the ...

IRVINE, Calif., February 28, 2025--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on ...